Findings could lead to advances in the use of bacteria to treat intestinal diseases, among other applications

Funds will help support research into brain and spinal cord injuries, as well as the "wasting away" experienced by those with AIDS and other diseases.

Meet Deep Genomics, a privately-held company that seeks to harness the power of deep learning to transform medicine.

Scientists have found compounds that fought off Ebola infections in mice.

Inspired by 1970s method, Stanford scientists find a way to go back and improve past scientific results.

Salk Institute findings on premature aging syndrome could lead to way of slowing or reversing aging process.

Scientists’ award-winning work uses innovative methods to make the production of anti-malarial drugs cheaper

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.

Project key to testing the effectiveness of potential treatments

A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus’ genetic material. The findings from the University of Chicago and the Massachusetts Institute of Technology could bolster efforts to develop the next generation of anti-viral treatments.